Physician

David A Holden, MD

According to 2025 Medicare claims, David Holden, MD (NPI: 1912007428) practices pulmonary disease in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Howard, MD. This provider's primary affiliated billing organization is JOHNS HOPKINS COMMUNITY PHYSICIANS, INC (NPI: 1578598868; TIN: 52-1467441) and primary practice location at 21044-2979.

Holden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 960 traditional Medicare patients, billed 28,375 HCPCS/CPT codes, and received $1,249,727 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,699 prescription claims across 630 beneficiaries totaling $2,046,612 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,416 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $75,952 to $1,249,727. Similarly, Part D prescription costs have moved sharply higher in recent years, from $902,394 to $2,046,612. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	695	1,786	$75,952
2016	467	1,684	$122,019
2017	504	1,684	$137,323
2018	479	1,746	$140,595
2019	623	1,757	$148,825
2020	650	1,386	$135,078
2021	736	1,600	$163,318
2022	796	1,804	$158,925
2023	789	1,710	$157,186
2024	960	28,375	$1,249,727

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	539	3,559	$902,394
2016	250	939	$256,635
2017	192	1,103	$293,293
2018	234	1,538	$512,502
2019	317	2,018	$696,061
2020	422	2,685	$1,185,520
2021	448	2,954	$1,649,839
2022	482	3,257	$2,105,637
2023	505	3,005	$1,810,404
2024	630	3,699	$2,046,612

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	582	2,300	$105,424
2016	365	1,274	$48,493
2017	273	1,047	$35,761
2018	387	1,303	$41,206
2019	431	1,304	$39,598
2020	467	1,469	$48,195
2021	488	1,598	$51,932
2022	582	1,635	$60,123
2023	583	1,744	$65,052
2024	891	2,416	$101,266

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	121	121	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	469	771	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	210	240	$68
94729	Test to examine how well the lungs exchange gases	109	110	$47
94010	Test to measure expiratory airflow and volume	152	156	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	573	30,450	$623,635
Ofev	Nintedanib Esylate	31	930	$406,147
Breo Ellipta	Fluticasone/Vilanterol	306	15,270	$194,034
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	134	7,664	$111,189
Pirfenidone	Pirfenidone	22	720	$99,904

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	36	258	$19,068
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$10,227
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	83	173	$8,971
A7032	Cushion for use on nasal mask interface, replacement only, each	N	45	90	$7,821
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	97	198	$7,303

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David A. Holden, MD?

Tedicare shows public-source Medicare data for David A. Holden, MD (NPI 1912007428), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Holden, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Holden, MD?

David A. Holden, MD is linked to JOHNS HOPKINS COMMUNITY PHYSICIANS, INC (billing NPI 1578598868) in the available physician profile data.

Does David A. Holden, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.